Nevada Jury Orders Drug Firms to Pay $162M in Hepatitis C Case
A Nevada jury is ordering pharmaceutical companies to pay $162.5 million in punitive damages in a lawsuit stemming from a Las Vegas hepatitis C outbreak in 2008.
The damages awarded Monday in Clark County District Court are on top of the $20.1 million in compensatory damages awarded to five plaintiffs Thursday after a jury found Teva Parenteral Medicines Inc., Baxter Healthcare Corp. and McKesson Corp. liable after a seven-week trial.
Plaintiffs’ lawyers had been seeking $600 million in punitive damages.
At least one of the drug companies is planning an immediate appeal.
Plaintiffs accused the drug companies of distributing dangerously large vials of the powerful anesthetic propofol to clinics where doctors and anesthesiologists are suspected of reusing vials – despite warnings that the practice could spread blood-borne diseases.
- La Niña Could Soon Arrive. What That Means for Winter Weather
- Subway Sandwiches Are Short on Meat, Lawsuit Claims
- Worker Injured While Drunk on the Job Wins Claim Approval
- Cargo-Ship Owner to Pay US $102M Over Baltimore Bridge Collapse, DOJ Says
- AccuWeather Increases Total Damage and Economic Loss Estimate From Helene to Between $225B-$250B
- Milton’s 152,180 Claims So Far to Mean New Pressure on Reinsurance, Rate Hikes
- Claims Confirm Hundreds of Israeli Buildings Marred by Iran’s Attack
- Viewpoint: Landmark Workers’ Comp Subrogation Decision in Nevada